IL17A and myeloid sarcoma: Multiple sclerosis (MS) is an autoimmune demyelinating and neurodegenerative disease of the central nervous system with increased levels of pro-inflammatory cytokines, such as TNFα, IFNγ, and IL-17A in periventricular foci and blood.